212 related articles for article (PubMed ID: 22713096)
1. Relationship between respiration deficiency and azole resistance in clinical Candida glabrata.
Peng Y; Dong D; Jiang C; Yu B; Wang X; Ji Y
FEMS Yeast Res; 2012 Sep; 12(6):719-27. PubMed ID: 22713096
[TBL] [Abstract][Full Text] [Related]
2. Relationships between respiration and susceptibility to azole antifungals in Candida glabrata.
Brun S; Aubry C; Lima O; Filmon R; Bergès T; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2003 Mar; 47(3):847-53. PubMed ID: 12604511
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
Schulz B; Knobloch M; Weber K; Ruhnke M
Int J Med Microbiol; 2012 Jul; 302(3):155-61. PubMed ID: 22664377
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
6. Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Vandeputte P; Tronchin G; Rocher F; Renier G; Bergès T; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2009 Jul; 53(7):3034-41. PubMed ID: 19380598
[TBL] [Abstract][Full Text] [Related]
7. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
8. Azole resistance of Candida glabrata in a case of recurrent fungemia.
Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
[TBL] [Abstract][Full Text] [Related]
9. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.
Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937
[TBL] [Abstract][Full Text] [Related]
10. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
11. Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients.
Farahyar S; Zaini F; Kordbacheh P; Rezaie S; Falahati M; Safara M; Raoofian R; Hatami K; Mohebbi M; Heidari M
Acta Med Iran; 2016 Jul; 54(7):458-64. PubMed ID: 27424018
[TBL] [Abstract][Full Text] [Related]
12. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
[TBL] [Abstract][Full Text] [Related]
14. The heme-binding protein Dap1 links iron homeostasis to azole resistance via the P450 protein Erg11 in Candida glabrata.
Hosogaya N; Miyazaki T; Nagi M; Tanabe K; Minematsu A; Nagayoshi Y; Yamauchi S; Nakamura S; Imamura Y; Izumikawa K; Kakeya H; Yanagihara K; Miyazaki Y; Kugiyama K; Kohno S
FEMS Yeast Res; 2013 Jun; 13(4):411-21. PubMed ID: 23496820
[TBL] [Abstract][Full Text] [Related]
15. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.
Jiang C; Dong D; Yu B; Cai G; Wang X; Ji Y; Peng Y
J Antimicrob Chemother; 2013 Apr; 68(4):778-85. PubMed ID: 23221625
[TBL] [Abstract][Full Text] [Related]
17. In-vivo selection of an azole-resistant petite mutant of Candida glabrata.
Bouchara JP; Zouhair R; LE Boudouil S; Renier G; Filmon R; Chabasse D; Hallet JN; Defontaine A
J Med Microbiol; 2000 Nov; 49(11):977-984. PubMed ID: 11073151
[TBL] [Abstract][Full Text] [Related]
18. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
19. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
[TBL] [Abstract][Full Text] [Related]
20. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
Vermitsky JP; Edlind TD
Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
